In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
28 authors.
Chuhan ShangDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Damian P BrightDepartment of Neuroscience, Physiology and Pharmacology, University College London, London, UK.ORCID 0000-0001-9130-2677 Martin MortensenDepartment of Neuroscience, Physiology and Pharmacology, University College London, London, UK.ORCID 0000-0002-5873-7107 Charlotte F JonesDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Wan-Na ChenDepartment of Pharmacology, University of Cambridge, Cambridge, UK.
Saad HannanDepartment of Neuroscience, Physiology and Pharmacology, University College London, London, UK.ORCID 0000-0003-4594-0808 Alexander W E DunnDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID 0000-0003-1504-499X Asma SoltaniDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Richard J TurnerDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID 0009-0006-8330-4828 Natasha M DugganDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Yin YuanDepartment of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.ORCID 0009-0001-5659-6566 Steven W HardwickCryoEM Facility, Department of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0001-9246-1864 Dimitri Y ChirgadzeCryoEM Facility, Department of Biochemistry, University of Cambridge, Cambridge, UK.ORCID 0000-0001-9942-0993 A Radu AricescuMRC Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge, UK.
Trevor G SmartDepartment of Neuroscience, Physiology and Pharmacology, University College London, London, UK.ORCID 0000-0002-9089-5375 Funding
Wellcome Trust
6 · The paper itselfAbstract
γ-Aminobutyric acid type-A (GABA
Indexed as
Receptors, GABA-ASingle-Domain AntibodiesAllosteric RegulationAnimalsCryoelectron MicroscopyHumansModels, MolecularProtein BindingReceptors, GABA-ASingle-Domain Antibodies
Identifiers
PMID42525743
PMCPMC13418544
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390